Gastric cytoprotection with L-363,586

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3700

Patent

active

044709749

ABSTRACT:
The somatostatin analog L-363,586 is a cyclic hexapeptide having the structure; cyclo-(N-methyl-Ala-Tyr-d-Trp-Lys-Val-Phe). L-363,586 has been found to be useful for inducing gastric cytoprotection via a mechanism not involving the inhibition of gastric acid secretions. Specific therapeutic utilities include, erosive gastritis, erosive esophagitis, inflammatory bowel disease and ethanol induced hemorrhagic gastric erosions.

REFERENCES:
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 4370348 (1983-01-01), Shriver
Chem. Abstr. vol. 98, (1983) 84216j.
Biol. Abstr. 65, (1978) 64207.
Chem. Abstr. vol. 98, (1983) 752v.
Chem. Abstr. vol. 94, (1981) 76964d.
Chem. Abstr. vol. 91, (1979) 117810j.
Chem. Abstr. vol. 87, (1977) 63200g.
Chem. Abstr. vol. 89, (1978) 53800e.
S. Szabo et al., Experimentia 38, 254 (1982) "Cytoprotection-Organoprotection by Somatostatin . . . ".
S. Szabo et al., Science 214, 200 (1981) "Sulfhydryl Compounds May Mediate Gastric Cytoprotection".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Gastric cytoprotection with L-363,586 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gastric cytoprotection with L-363,586, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gastric cytoprotection with L-363,586 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1194447

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.